Bolden Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 6

Bolden Therapeutics General Information

Description

Operator of a biotechnology company intended to improve the lives of patients suffering from neurodegeneration. The company develops a therapeutic compound that utilizes a key molecular pathway to promote the birth of new neurons in the adult brain, enabling users to treat central nervous system diseases such as Alzheimer's disease and ischemic stroke.

Contact Information

Website
www.boldentherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 225 Dyer Street
  • Floor 2
  • Providence, RI 02903
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 225 Dyer Street
  • Floor 2
  • Providence, RI 02903
  • United States

Bolden Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bolden Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 17-Jan-2024 $1.5M Completed Startup
4. Accelerator/Incubator Completed Startup
3. Grant 01-Jan-2024 Completed Startup
2. Grant 18-Sep-2022 $904K Completed Startup
1. Grant 15-Sep-2021 $897K Completed Startup
To view Bolden Therapeutics’s complete valuation and funding history, request access »

Bolden Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to improve the lives of patients suffering from neurodegeneration. The comp
Drug Discovery
Providence, RI
5 As of 2025

King of Prussia, PA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bolden Therapeutics Competitors (58)

One of Bolden Therapeutics’s 58 competitors is XyloCor Therapeutics, a Venture Capital-Backed company based in King of Prussia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
XyloCor Therapeutics Venture Capital-Backed King of Prussia, PA
Cytokinetics Formerly VC-backed South San Francisco, CA
T3D Therapeutics Venture Capital-Backed Durham, NC
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Cognition Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 58 competitors. Get the full list »

Bolden Therapeutics Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Bolden Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023210230-A1 Musk-targeting oligonucleotides Pending 20-Jan-2022
EP-4466360-A1 Musk-targeting oligonucleotides Pending 20-Jan-2022
EP-4466360-A4 Musk-targeting oligonucleotides Pending 20-Jan-2022
US-20250257359-A1 Musk-targeting oligonucleotides Pending 20-Jan-2022
WO-2023141302-A1 Musk-targeting oligonucleotides Inactive 20-Jan-2022 C12N15/1138
To view Bolden Therapeutics’s complete patent history, request access »

Bolden Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bolden Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altitude Ventures Venture Capital Minority
LifeSpan Vision Ventures Venture Capital Minority
Resolute Ventures Venture Capital Minority
Slater Technology Fund Venture Capital Minority
National Institutes of Health Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Bolden Therapeutics FAQs

  • When was Bolden Therapeutics founded?

    Bolden Therapeutics was founded in 2019.

  • Where is Bolden Therapeutics headquartered?

    Bolden Therapeutics is headquartered in Providence, RI.

  • What is the size of Bolden Therapeutics?

    Bolden Therapeutics has 5 total employees.

  • What industry is Bolden Therapeutics in?

    Bolden Therapeutics’s primary industry is Drug Discovery.

  • Is Bolden Therapeutics a private or public company?

    Bolden Therapeutics is a Private company.

  • What is Bolden Therapeutics’s current revenue?

    The current revenue for Bolden Therapeutics is .

  • How much funding has Bolden Therapeutics raised over time?

    Bolden Therapeutics has raised $1.5M.

  • Who are Bolden Therapeutics’s investors?

    Altitude Ventures, LifeSpan Vision Ventures, Resolute Ventures, Slater Technology Fund, and National Institutes of Health are 5 of 6 investors who have invested in Bolden Therapeutics.

  • Who are Bolden Therapeutics’s competitors?

    XyloCor Therapeutics, Cytokinetics, T3D Therapeutics, Neurona Therapeutics, and Cognition Therapeutics are some of the 58 competitors of Bolden Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process